Australia markets closed

AVXL Jul 2022 15.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.25000.0000 (0.00%)
As of 03:45PM EDT. Market open.
Full screen
Previous close0.2500
Open0.2000
Bid0.0000
Ask0.0000
Strike15.00
Expiry date2022-07-15
Day's range0.1500 - 0.2500
Contract rangeN/A
Volume69
Open interest1.8k
  • Zacks

    Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 238%: Here's is How to Trade

    The average of price targets set by Wall Street analysts indicates a potential upside of 238.3% in Anavex Life Sciences (AVXL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  • Zacks

    Celldex (CLDX) Initiates Phase II Chronic Skin Disorder Study

    Celldex (CLDX) initiates dosing in a mid-stage study designed to evaluate its antibody candidate, barzolvolimab, for treating patients with chronic spontaneous urticaria.

  • GlobeNewswire

    Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release

    NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announces Anavex’s very first Educational Video News Release, which can be accessed via Anavex's newsroom. To